Coya Therapeutics, Inc.
COYA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001835022
No open-market purchases or sales by Coya Therapeutics, Inc. insiders were filed in the last 90 days; 54 institutions reported holding it in 13F filings for Q2 2026, worth $45.5M in total; Greenlight Capital is the only superinvestor holding it.
Holders of 5% or more of COYA
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Coya Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| DME Capital Management, LPSuperinvestorGreenlight Capital | 13G/A | 9.90%1.65M shares | – | Feb 14, 20251 filing | Feb 14, 2025 | SEC |
| Hirschman Orin | 13G/A | 8.00%1.33M shares | – | Feb 10, 20251 filing | Feb 10, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
2 Schedule 13D and 13G filings on Coya Therapeutics, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Feb 14, 20254:26 PM ET | DME Capital Management, LPand 3 othersSuperinvestorGreenlight Capital | 13G/A | 9.90%1.65M shares | – | Dec 31, 2024 | SEC |
| Feb 10, 20258:35 AM ET | Hirschman Orinand 1 other | 13G/A | 8.00%1.33M shares | – | Dec 31, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Coya Therapeutics, Inc. shares.
No Form 144 notices for Coya Therapeutics, Inc. are on file.